Björses Katarina, Holst Jan
Vascular Center, Malmö University Hospital, Lund University, Sweden.
J Trauma. 2009 Mar;66(3):602-11. doi: 10.1097/TA.0b013e3181823533.
Damage control is valuable in hemodynamically unstable trauma patients. To improve the hemostasis of packing, topical hemostatic agents have been suggested. The effects of such agents are unclear in trauma situations. The purpose of this study was to investigate the hemostatic capacity, and the stability of the hemostatic clot, of four substances with different mode of action in an experimental traumatic bleeding model.
A standardized heminefrectomy was performed in 180 heparinized and normotensive Sprauge-Dawley rats. Four different substances were studied (separately and in combinations) in a randomized fashion: gelatin (sponge and matrix), bovine thrombin, freeze-dried recombinant factor VIIa (rFVIIa), and microporous polysaccharide hemospheres. Eight treatment groups (15 animals/group) were considered, primary endpoint was hemostasis within 20 minutes of observation. The effective treatment groups were evaluated in a second set in the same experimental model, but with a prolonged observation time after hemostasis (60 minutes) to control the stability of the clot.
Those animals treated with gelatin in the comparative study, with and without thrombin or rFVIIa, obtained hemostasis. Thrombin and rFVIIa alone did not have any hemostatic capacity. Only 20% to 25% of the animals obtained hemostasis with microporous polysaccharide hemospheres alone or in combination with rFVIIa. In the prolonged observation study, gelatin alone and in combination with thrombin or rFVIIa was studied. On average, 34% (20%-54%) of the animals rebled with no significant difference between the treatment groups.
Gelatin-containing products provided a fast hemostasis in this experimental model. One third of the animals rebled, regardless of whether thrombin or rFVIIa was added. Further studies are demanded to confirm these results clinically.
损伤控制对于血流动力学不稳定的创伤患者具有重要价值。为改善填塞止血效果,有人提出使用局部止血剂。但此类药物在创伤情况下的效果尚不清楚。本研究旨在探讨四种作用方式不同的物质在实验性创伤出血模型中的止血能力及止血凝块的稳定性。
对180只肝素化且血压正常的Sprauge-Dawley大鼠进行标准化半肝切除术。以随机方式研究四种不同物质(单独及联合使用):明胶(海绵和基质)、牛凝血酶、冻干重组凝血因子VIIa(rFVIIa)和微孔多糖微球。考虑了八个治疗组(每组15只动物),主要终点是观察20分钟内止血情况。在同一实验模型的第二组中对有效治疗组进行评估,但止血后延长观察时间(60分钟)以控制凝块的稳定性。
在比较研究中,使用明胶治疗的动物,无论是否添加凝血酶或rFVIIa,均实现了止血。单独使用凝血酶和rFVIIa没有任何止血能力。仅20%至25%的动物单独使用微孔多糖微球或与rFVIIa联合使用时实现了止血。在延长观察研究中,研究了单独使用明胶以及与凝血酶或rFVIIa联合使用的情况。平均而言,34%(20%-54%)的动物再次出血,各治疗组之间无显著差异。
含明胶产品在该实验模型中能快速止血。三分之一的动物再次出血,无论是否添加凝血酶或rFVIIa。需要进一步研究以临床证实这些结果。